Isabelle Mahé on Delphi Consensus on Aspects Relating to the Antithrombotic Therapy for Cancer Patients
Isabelle Mahé, Head of Internal Medicine, Louis Mourier Hospital, APHP, Paris Cité University, reposted from SERENITY on LinkedIn:
”A two-round Delphi process was used to achieve consensus on aspects relating to the antithrombotic therapy deprescribing discussions and process in end-of-life cancer patients across Europe and different specialities.
The perspective is to support informed decision-making, reduce complications, and improve quality of life in palliative care patients.”
Quoting SERENITY‘s post:
”Developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: Results of a European Delphi study
For the DELPHI Serenity Group
Isabelle Mahé Anette Arbjerg Højen
Prof.Dr.Stavros Konstantinides
Sebastian Szmit
Denise Abbel
Laurent Bertoletti
Adrian Edwards
Jacobijn Gussekloo
Johan Langendoen
Simon Mooijaart
Stella Trompet
Erik Klok
Professor Simon Noble
Camille Couffignal”
Read the full article here.
Article: Developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: Results of a European Delphi study
Authors: For the DELPHI Serenity Group – Skerdi Haviarie, Nassima Si Mohammed, Anette Arbjerg Højeng, Carme Fonth, Stavros Konstantinides, Marieke Kruip, Luigi Maiorana, Sebastian Szmit, Denise Abel, Laurent Bertoletti, Adrian Edwards, Michelle Edwards, Alessandra Gaval, Jacobijn Gussekloo, Miriam Johnson, Rashmi Kumar, Johan Langendoen, Kate Lifford, Simon Mooijaart, Mark Pearson, Johanneke Portielje, Kathy Seddon, Stella Trompet, Hélène Helfer, Frederikus Klok, Simon Noble, Camille Couffignal
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 24, 2026, 18:13Chokri Ben Lamine: Ruxolitinib – Comprehensive Clinical Reference
-
Aug 24, 2026, 18:10Yazan Abou-Ismail: ClotCast Episode 8 – What Are Platelets?
-
Aug 24, 2026, 17:11Kristin Neves: Which Hematologic Parameters Guide Your PV Treatment Decisions?
-
Aug 24, 2026, 17:00Should Hormone Therapy Automatically Stop After a Thrombosis? – Thrombosis Canada
-
Aug 24, 2026, 16:52Davide Capodanno: 10 Trials to Watch at the ESC Hot Lines
-
Aug 24, 2026, 16:48Mohd Ashhad: The Science Behind a Safe Transfusion
-
Aug 24, 2026, 16:38PCSK9i Is a Powerful Lipid-Lowering Strategy – But Is It Also Anti-Inflammatory?- JACC Journals
-
Aug 24, 2026, 16:36Alejandro González Veliz։ Does ACC/AHA Lesion Complexity Still Matter?
-
Aug 24, 2026, 16:21Kamlesh Darji: Paraneoplastic Syndromes – Tumor with or without Mediator